| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Katharine Barnard, Shideh Majidi, Mark A Clements, Tadej Battelino, Eric Renard, Kelly L Close, Lucia Novak, Partha Kar, Yiduo W. RESCUE Collaborative Community: A New Initiative to Reduce Rates of Intended Self-Injury and Suicide Amongst People with Diabetes. Diabetes technology & therapeutics. 2022-03-03. PMID:35238618. |
this is particularly important in the setting of advanced technologies in t1d, which offer both easier methods of self-injurious behaviours through insulin misuse and also can act as identification tools to identify risk insulin behaviours and provide opportunities to develop interventions and prevention efforts in those with depression and suicidal ideation/behavior/acts. |
2022-03-03 |
2023-08-13 |
Not clear |
| b' Cynthia V Calkin, K N Roy Chengappa, Kathleen Cairns, Jacob Cookey, Jessica Gannon, Martin Alda, Claire O\'Donovan, Claire Reardon, Marcos Sanches, Martina R\\xc5\\xafzickov\\xc3\\xa. Treating Insulin Resistance With Metformin as a Strategy to Improve Clinical Outcomes in Treatment-Resistant Bipolar Depression (the TRIO-BD Study): A Randomized, Quadruple-Masked, Placebo-Controlled Clinical Trial. The Journal of clinical psychiatry. vol 83. issue 2. 2022-02-04. PMID:35120288.' |
treating insulin resistance with metformin as a strategy to improve clinical outcomes in treatment-resistant bipolar depression (the trio-bd study): a randomized, quadruple-masked, placebo-controlled clinical trial. |
2022-02-04 |
2023-08-13 |
Not clear |
| Hussein Kadhem Al-Hakeim, Hadi Hasan Hadi, Ghoufran Akeel Jawad, Michael Mae. Intersections between Copper, β-Arrestin-1, Calcium, FBXW7, CD17, Insulin Resistance and Atherogenicity Mediate Depression and Anxiety Due to Type 2 Diabetes Mellitus: A Nomothetic Network Approach. Journal of personalized medicine. vol 12. issue 1. 2022-01-21. PMID:35055338. |
intersections between copper, β-arrestin-1, calcium, fbxw7, cd17, insulin resistance and atherogenicity mediate depression and anxiety due to type 2 diabetes mellitus: a nomothetic network approach. |
2022-01-21 |
2023-08-13 |
Not clear |
| Hussein Kadhem Al-Hakeim, Hadi Hasan Hadi, Ghoufran Akeel Jawad, Michael Mae. Intersections between Copper, β-Arrestin-1, Calcium, FBXW7, CD17, Insulin Resistance and Atherogenicity Mediate Depression and Anxiety Due to Type 2 Diabetes Mellitus: A Nomothetic Network Approach. Journal of personalized medicine. vol 12. issue 1. 2022-01-21. PMID:35055338. |
the present study delineated the effects of serum levels of copper, zinc, β-arrestin-1, fbxw7, lactosylceramide (laccer), serotonin, calcium, magnesium on severity of depression and anxiety in 58 men with t2dm and 30 healthy male controls beyond the effects of insulin resistance (ir) and atherogenicity. |
2022-01-21 |
2023-08-13 |
Not clear |
| Nils Kappelmann, Benjamin I Perry, Golam M Khandake. Prenatal and Childhood Immuno-Metabolic Risk Factors for Adult Depression and Psychosis. Harvard review of psychiatry. vol 30. issue 1. 2022-01-07. PMID:34995032. |
developmental trajectories reflecting persistently high insulin levels during childhood and adolescence are associated with a higher risk of psychosis in adulthood, whereas increased adiposity during and after puberty is associated with the risk of depression. |
2022-01-07 |
2023-08-13 |
Not clear |
| J Blair Price, Clarissa G Yates, Brooke A Morath, Sam K Van De Wakker, Nathanael J Yates, Kim Butters, Mark A Frye, Sean L McGee, Susannah J Ty. Lithium augmentation of ketamine increases insulin signaling and antidepressant-like active stress coping in a rodent model of treatment-resistant depression. Translational psychiatry. vol 11. issue 1. 2021-12-11. PMID:34824208. |
lithium augmentation of ketamine increases insulin signaling and antidepressant-like active stress coping in a rodent model of treatment-resistant depression. |
2021-12-11 |
2023-08-13 |
human |
| Jennifer M Erichsen, Jim R Fadel, Lawrence P Reaga. Peripheral versus central insulin and leptin resistance: Role in metabolic disorders, cognition, and neuropsychiatric diseases. Neuropharmacology. vol 203. 2021-12-07. PMID:34762922. |
both preclinical and clinical findings have indicated that insulin and leptin resistance are associated with cognitive deficits and neuropsychiatric diseases such as depression. |
2021-12-07 |
2023-08-13 |
Not clear |
| Kathleen T Watson, Julia F Simard, Victor W Henderson, Lexi Nutkiewicz, Femke Lamers, Natalie Rasgon, Brenda Pennin. Association of Insulin Resistance With Depression Severity and Remission Status: Defining a Metabolic Endophenotype of Depression. JAMA psychiatry. vol 78. issue 4. 2021-12-03. PMID:33263725. |
association of insulin resistance with depression severity and remission status: defining a metabolic endophenotype of depression. |
2021-12-03 |
2023-08-13 |
Not clear |
| Carla Nasca, Josh Dobbin, Benedetta Bigio, Kathleen Watson, Paolo de Angelis, Marin Kautz, Ashly Cochran, Aleksander A Mathé, James H Kocsis, Francis S Lee, James W Murrough, Bruce S McEwen, Natalie Rasgo. Insulin receptor substrate in brain-enriched exosomes in subjects with major depression: on the path of creation of biosignatures of central insulin resistance. Molecular psychiatry. vol 26. issue 9. 2021-11-18. PMID:32536688. |
insulin receptor substrate in brain-enriched exosomes in subjects with major depression: on the path of creation of biosignatures of central insulin resistance. |
2021-11-18 |
2023-08-13 |
human |
| Stephanie Fulton, Léa Décarie-Spain, Xavier Fioramonti, Bruno Guiard, Shingo Nakajim. The menace of obesity to depression and anxiety prevalence. Trends in endocrinology and metabolism: TEM. 2021-11-09. PMID:34750064. |
resulting metabolic and vascular dysfunction, including inflammation, insulin and leptin resistance, and hypertension, have emerged as key risks to depression and anxiety development. |
2021-11-09 |
2023-08-13 |
Not clear |
| Anouk F J Geraets, Sebastian Köhler, Rutendo Muzambi, Casper G Schalkwijk, Anke Oenema, Simone J P M Eussen, Pieter C Dagnelie, Coen D A Stehouwer, Nicolaas C Schaper, Ronald M A Henry, Carla J H van der Kallen, Anke Wesselius, Annemarie Koster, Frans R J Verhey, Miranda T Schra. The association of hyperglycaemia and insulin resistance with incident depressive symptoms over 4 years of follow-up: The Maastricht Study. Diabetologia. vol 63. issue 11. 2021-11-01. PMID:32757152. |
however, it remains unclear whether hyperglycaemia and insulin resistance are directly involved in the aetiology of depression. |
2021-11-01 |
2023-08-13 |
Not clear |
| Annelies Brouwer, Daniël H van Raalte, Femke Lamers, Femke Rutters, Petra J M Elders, Eus J W Van Someren, Frank J Snoek, Aartjan T F Beekman, Marijke A Bremme. Insulin resistance as a marker for the immune-metabolic subtype of depression. Journal of affective disorders. vol 295. 2021-11-01. PMID:34565592. |
insulin resistance as a marker for the immune-metabolic subtype of depression. |
2021-11-01 |
2023-08-13 |
Not clear |
| Emma L M Clark, Lauren D Gulley, Mark A Prince, Milena Casamassima, Natalia Sanchez, Virginia Jimenez, Sarah A Johnson, Reagan L Miller, Isabella Conte, Jill L Kaar, Stacey L Simon, Christopher Melby, Rachel G Lucas-Thompson, Lauren B Shomake. The role of mindfulness in associations among depression symptoms, sleep duration, and insulin resistance in adolescents. Journal of behavioral medicine. vol 44. issue 5. 2021-10-28. PMID:33884531. |
the role of mindfulness in associations among depression symptoms, sleep duration, and insulin resistance in adolescents. |
2021-10-28 |
2023-08-13 |
Not clear |
| Emma L M Clark, Lauren D Gulley, Mark A Prince, Milena Casamassima, Natalia Sanchez, Virginia Jimenez, Sarah A Johnson, Reagan L Miller, Isabella Conte, Jill L Kaar, Stacey L Simon, Christopher Melby, Rachel G Lucas-Thompson, Lauren B Shomake. The role of mindfulness in associations among depression symptoms, sleep duration, and insulin resistance in adolescents. Journal of behavioral medicine. vol 44. issue 5. 2021-10-28. PMID:33884531. |
sleep difficulties may be one explanatory factor in the association between depression and insulin resistance; yet, explicit tests of this hypothesis are lacking. |
2021-10-28 |
2023-08-13 |
Not clear |
| Emma L M Clark, Lauren D Gulley, Mark A Prince, Milena Casamassima, Natalia Sanchez, Virginia Jimenez, Sarah A Johnson, Reagan L Miller, Isabella Conte, Jill L Kaar, Stacey L Simon, Christopher Melby, Rachel G Lucas-Thompson, Lauren B Shomake. The role of mindfulness in associations among depression symptoms, sleep duration, and insulin resistance in adolescents. Journal of behavioral medicine. vol 44. issue 5. 2021-10-28. PMID:33884531. |
we determined if there was an indirect effect of depression symptoms on insulin resistance through sleep duration in adolescents at risk for excess weight gain. |
2021-10-28 |
2023-08-13 |
Not clear |
| Polina Tsarkova, Nevena Chakarova, Rumyana Dimova, Greta Grozeva, Ani Todorova, Mina Serdarova, Martina Salkova, Tsvetalina Tankov. CSII is related to more stable glycemia in adults with type 1 diabetes. Endocrine. 2021-10-25. PMID:34694598. |
the purpose of the present study was to compare the basic glycemic control parameters-hba1c, cv%, and hypoglycemia, as well as quality of life and depression score in patients with type 1 diabetes using continuous subcutaneous insulin infusion (csii) versus multiple daily injections (mdi). |
2021-10-25 |
2023-08-13 |
Not clear |
| Aarthi Ethirajulu, Almothana Alkasabera, Chike B Onyali, Comfort Anim-Koranteng, Hira E Shah, Nitin Bhawnani, Jihan A Mostaf. Insulin Resistance, Hyperandrogenism, and Its Associated Symptoms Are the Precipitating Factors for Depression in Women With Polycystic Ovarian Syndrome. Cureus. vol 13. issue 9. 2021-10-22. PMID:34667688. |
insulin resistance, hyperandrogenism, and its associated symptoms are the precipitating factors for depression in women with polycystic ovarian syndrome. |
2021-10-22 |
2023-08-13 |
Not clear |
| Aarthi Ethirajulu, Almothana Alkasabera, Chike B Onyali, Comfort Anim-Koranteng, Hira E Shah, Nitin Bhawnani, Jihan A Mostaf. Insulin Resistance, Hyperandrogenism, and Its Associated Symptoms Are the Precipitating Factors for Depression in Women With Polycystic Ovarian Syndrome. Cureus. vol 13. issue 9. 2021-10-22. PMID:34667688. |
the various pathophysiological mechanisms that lead to depression are insulin resistance, disturbance in the hypothalamic pituitary adrenal (hpa) axis, hyperandrogenism and its clinical presentation, obesity, and infertility. |
2021-10-22 |
2023-08-13 |
Not clear |
| Maureen Monaghan, Linda J Herbert, Fran R Cogen, Randi Streisan. Sleep Behaviors and Parent Functioning in Young Children With Type 1 Diabetes. Children's health care : journal of the Association for the Care of Children's Health. vol 41. issue 3. 2021-10-21. PMID:25035574. |
however, increased child bedtime resistance and behavioral insomnia were related to greater parent stress, anxiety, and depression and use of an intensive insulin regimen. |
2021-10-21 |
2023-08-13 |
human |
| Nicole Vogelzangs, Brenda W Pennin. Cortisol and Insulin in Depression and Metabolic Syndrome. Psychoneuroendocrinology. vol 32. issue 7. 2021-10-20. PMID:18670578. |
cortisol and insulin in depression and metabolic syndrome. |
2021-10-20 |
2023-08-12 |
Not clear |